School of Medicine
Showing 681-700 of 2,425 Results
-
Thomas Glynn
Adjunct Lecturer, Medicine - Med/Stanford Prevention Research Center
BioBiosketch - Thomas J. Glynn, M.A., M.S., Ph.D. (psych.)
Dr. Glynn is, from 2014 to the present, Adjunct Lecturer, Stanford Prevention Research Center, Stanford University School of Medicine and Executive Team Member, Mayo Clinic Global Bridges Initiative. From 1998 to 2014, he was Director, Cancer Science and Trends and Director, International Cancer Control at the American Cancer Society (ACS). In these positions, he advised the ACS about emerging research and policy issues in cancer prevention and control, recommended cancer prevention and control research and policies, and participated in the development of an international cancer control program aimed at promoting cancer prevention-related research, advocacy, treatment, and policy change, particularly in middle- and low-income nations.
Prior to the ACS, Dr. Glynn was, from 1991 to 1994, Associate Director of the U.S. National Cancer Institute's (NCI) Cancer Control Science Program and, from 1991 to 1998, Chief of the NCI's Cancer Control Extramural Research Branch. There, he directed a national program of research aimed at reducing the incidence and prevalence of cancer, primarily through dietary change, tobacco use reduction, and adherence to cancer screening guidelines. From 1983 to 1991, he was Research Director for the NCI's Smoking, Tobacco, and Cancer Program and from 1978 to 1983, he was a Research Psychologist at the National Institute on Drug Abuse.
Dr. Glynn has published widely on cancer and tobacco use prevention and control, both in the scientific literature and for consumer, professional, and patient education and is co-developer of the 4A (now 5A) protocol for the treatment of tobacco dependence. In addition to his work at the ACS and NCI, he has served as a consultant on cancer control and tobacco issues to such groups as the National Academy of Sciences/Institute of Medicine, the National Research Council, the Robert Wood Johnson Foundation, the WHO, a variety of pharmaceutical organizations, and national, state and local governments.
He has also served as a Senior Scientific Reviewer for the U.S. Surgeon General's Reports on Tobacco and Health, as Director of the World Health Organization Study of Health, Economic, and Policy Implications of Tobacco Growth and Consumption in Developing Countries, and has been active in tobacco control programs in Eastern Europe, Central America, and India. He is a Fellow of the Society for Research on Nicotine and Tobacco and his awards include the U.S. National Institutes of Health Merit Award, the Polish Ministry of Health Service Award, the Guatemala National Council for Tobacco Prevention and Control Meritorious Service Award, the Society for Research on Nicotine and Tobacco John Slade Award, and the American Society of Preventive Oncology Joseph W. Cullen Memorial Award. -
Aparna Goel
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsDr. Goel is interested in studying the complications and management of patients with end-stage liver disease, including infections, bleeding and encephalopathy. As the waitlist for liver transplantation continues to grow, many patients develop consequences of decompensated liver disease. It is becoming increasingly important to improve our understanding and care of these complications in order to optimize the quality of life for this growing population of patients.
She is also particularly interested in the management of patients with autoimmune liver disease including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis among others. -
Amit Gohil
Clinical Associate Professor (Affiliated), Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Staff, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioMy main practice is at County Hospital of Santa Clara, where my time is split between Pulmonary Clinic, Pulmonary Physiology Lab and Medical Intensive Care.
Other Clinical Interests include neurocritical care, Mab therapy for asthma,. and management of toxin induced pulmonary hypertension
My research interests are moving into the use of Data Science to answer clinical questions. I am currently in the process of becoming familiar with R as a coding language to examine large clinical data sets and hope to move into machine learning algorithms to improve the pulmonary health of our county population. -
David Edward Goldenberg
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr Goldenberg completed training at UCLA, Geisel School of Medicine at Dartmouth, Tufts Medical Center, and Cedars Sinai Medical Center. In addition to a gastroenterology fellowship, he graduated with a Masters in Healthcare Delivery Science at Cedars Sinai Medical Center. He has a passion for medical education and enjoys teaching medical students, residents, and fellows as a Clinician Educator. His research focuses on Healthcare Delivery with an emphasis on maximizing value-based healthcare and medical innovation. He has an additional interest in translational research with multiple publications and patent applications for medical devices. He has unique clinical expertise in fecal microbiota transplantation.
-
Paul Goldschmidt
Affiliate, Med/DOM Faculty Leadership
BioBachelor of Science - Hamburg University of Applied Sciences
Class Tutor - Experimental Physics
Software Engineer / Student Researcher - Stanford Biodesign Digital Health
Founder, CEO @ Dotreflection GmbH - Startup for large-scale medical communication platforms
Member - Permafrost Young Researchers Network (PYRN)
Member - German Physical Society
Scholar, Spokesperson - German Academic Scholarship Foundation (Studienstiftung des Deutschen Volkes) -
Zinaida Good, Ph.D.
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsOur laboratory integrates cutting-edge synthetic biology, immunology, and machine learning to engineer T cell therapies for cancer and autoimmune diseases. We have 3 research areas:
- Analysis of clinical single-cell and spatial transcriptomics datasets from T cell therapy trials to identify mechanisms of resistance
- Building AI systems to generate T cell designs predicted to improve patient outcomes
- Genetic screens of novel T cell designs in models that mimic key mechanisms of resistance -
Jorg Goronzy
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly InterestsT cell homeostasis and function with age
